Cell Reports · 2023 · 32 citations · 51 references
MedicineImmunologyOncologyCancer ImmunologyTumor ImmunologyTumor MicroenvironmentImmune Cell InfiltrationImmune Evasion In CancerInflammatory SignalingSignal Transduction In CancerT Cell Responses To TumorsTumor Immune MicroenvironmentFatty AcidsImmunosuppressive FunctionImmunosuppressive Myeloid CellsInflammation Modulation By Fatty AcidsSaturated Fatty AcidsSuppressive Myeloid CellsTumor Microenvironment RegulationUnsaturated Fatty Acids
Oncogenes destabilize STING in epithelial cell-derived cancer cells, such as head and neck squamous cell carcinomas (HNSCCs), to promote immune escape. Despite the abundance of tumor-infiltrating myeloid cells, HNSCC presents notable resistance to STING stimulation. Here, we show how saturated fatty acids in the microenvironment dampen tumor response to STING stimulation. Using single-cell analysis, we found that obesity creates an IFN-I-deprived tumor microenvironment with a massive expansion of suppressive myeloid cell clusters and contraction of effector T cells. Saturated fatty acids, but not unsaturated fatty acids, potently inhibit the STING-IFN-I pathway in HNSCC cells. Myeloid cells from obese mice show dampened responses to STING stimulation and are more suppressive of T cell activation. In agreement, obese hosts exhibited increased tumor burden and lower responsiveness to STING agonist. As a mechanism, saturated fatty acids induce the expression of NLRC3, depletion of which results in a T cell inflamed tumor microenvironment and IFN-I-dependent tumor control.
51
Autophagy in the Pathogenesis of Disease
Beth Levine, Guido Kroemer · Cell · 2008 · 7K citations · Full text
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text
Medicine, Oncology, Metastasis +5
Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.7K citations · Full text
Medicine, Oncology, Pharmacology +11